Company/Division name | Merck & Co., Inc. |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 150 |
What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
Year reshoring announced: | 2022 |
Capital investment ($): | 1000 |
City reshored to: | Elkton |
State(s) reshored to: | VA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | human papillomavirus (HPV) vaccine |
What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |